PF-02545920 manufacturers
- PF-02545920
-
- $2500.00
-
2026-04-20
- CAS:898563-49-0
- Purity:
- Supply Ability: 10g
|
| | PF-02545920 Basic information |
| Product Name: | PF-02545920 | | Synonyms: | PF-02545920;Quinoline, 2-[[4-[1-methyl-3-(4-pyridinyl)-1H-pyrazol-4-yl]phenoxy]methyl]-;PF 02545920,PF02545920;RMA-527 | | CAS: | 898563-49-0 | | MF: | C25H20N4O | | MW: | 392.45 | | EINECS: | | | Product Categories: | | | Mol File: | 898563-49-0.mol |  |
| | PF-02545920 Chemical Properties |
| Boiling point | 568.6±50.0 °C(Predicted) | | density | 1.21±0.1 g/cm3(Predicted) | | solubility | DMSO: Sparingly Soluble: 1-10 mg/mL | | pka | 3.69±0.48(Predicted) |
| | PF-02545920 Usage And Synthesis |
| Uses | PDE10A-IN-4 (compound 38) is a compound used to inhibit schizophrenia. As a PDE10A inhibitor, it is less effective than placebo in inhibiting acute schizophrenia and does not show antipsychotic effect. | | References | [1] Synthesis and in vivo evaluation of novel quinoline derivatives as phosphodiesterase 10A inhibitors |
| | PF-02545920 Preparation Products And Raw materials |
|